Clinical studies recruiting near Fremont

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Kaiser Permanente-Fremont · National Cancer Institute (NCI) · NCT05564390 Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Phase N/A · Galderma Investigational Site 8224 · Galderma R&D · NCT06988605 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Oncology Hematology West, PC dba Nebraska Cancer Specialists · Pfizer · NCT06758401 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Palo Alto Medical Foundation-Fremont · NRG Oncology · NCT05624996 A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Pa
Phase 4 · Center For Dermatology Clinical Research, Inc. · Eli Lilly and Company · NCT06857942 A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
Phase 2 · Center for Dermatology Clinical Research, Inc. · Takeda · NCT07108283 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · Kaiser Permanente-Fremont · NRG Oncology · NCT05946213 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · West Coast Kidney Institute · Boehringer Ingelheim · NCT07220083 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Kaiser Permanente-Fremont · NRG Oncology · NCT05174169 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Kaiser Permanente-Fremont · Alliance for Clinical Trials in Oncology · NCT06632327 Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome
Phase 2/Phase 3 · Center for Dermatology Clinical Research · Quoin Pharmaceuticals · NCT07538583 Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastati
Phase 3 · Kaiser Permanente-Fremont · Alliance for Clinical Trials in Oncology · NCT06931340 A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Phase 3 · Panoramic Health - West Coast Kidney Institute (Fremont) · Takeda · NCT06963827 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Kaiser Permanente-Fremont · Alliance for Clinical Trials in Oncology · NCT06876714 This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate
Phase N/A · Center for Dermatology Clinical Research- Site Number : 8400 · Sanofi · NCT07290803 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · National Cancer Institute (NCI) · NCT04269902 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · Kaiser Permanente-Fremont · NRG Oncology · NCT06748222 Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Phase 3 · Center For Dermatology Clinical Research Inc. · Sun Pharmaceutical Industries, Inc. · NCT07133308 Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Washington Health · Alliance for Clinical Trials in Oncology · NCT04242095 Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-S
Phase 3 · Kaiser Permanente-Fremont · National Cancer Institute (NCI) · NCT06498635 A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis
Phase 1 · Sitryx Clinical Site · Sitryx Therapeutics Ltd · NCT07558668 Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult
Phase 3 · Palo Alto Medical Foundation - Fremont Center · Pfizer · NCT07222800 Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Phase 3 · Palo Alto Medical Foundation-Fremont · ECOG-ACRIN Cancer Research Group · NCT04566328 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Kaiser Permanente-Fremont · NRG Oncology · NCT04852887 Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
Phase 3 · Center for Dermatology Clinical Research, Inc · Sun Pharmaceutical Industries, Inc. · NCT07144852 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109 mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Neg
Phase 3 · Kaiser Permanente-Fremont · Alliance for Clinical Trials in Oncology · NCT05677490 Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
Phase 3 · Vanda Investigational Site · Vanda Pharmaceuticals · NCT07362017 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · Palo Alto Medical Foundation-Fremont · National Cancer Institute (NCI) · NCT06058377 A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in
Phase 3 · Center for Dermatology Clinical Research- Site Number : 8401 · Sanofi · NCT06241118

Look up another city

Look up another condition